Home > Guidance for the prevention, testing, treatment and management of hepatitis C in primary care.

Ford, Chris and Halliday, Kate and Foster, Graham and Gore, Charles and Jack, Kate and Rowan, Nicola and Sander-Hess, Carola and Saville, Sebastian and Thomson, Brian and Willott, Stephen and Wright, Nat and Young, David [Royal College of General Practitioners, UK] . (2007) Guidance for the prevention, testing, treatment and management of hepatitis C in primary care. London: Royal College of General Practioners. 52 p.

[img]
Preview
PDF (Prevention, testing, treatment and management of hepatitis C in primary care) - Published Version
3MB

URL: http://www.rcgp.org.uk/professional_development/su...

1. Hepatitis C infection is an under-diagnosed (five out of every six people infected are undiagnosed) and under-treated important cause of morbidity and mortality.
2. Hepatitis C is a common and potentially curable disease, but only 1 to 2% of infected people are currently receiving National Institute of Clinical Excellence (NICE) recommended therapy.
3. Every general practitioner is likely to have between 8 to 18 infected individuals per GP, based on an average list size of 1,800 and, partly depending upon local population demographics. Many of these patients may not be diagnosed and knowledge about HCV in population and primary care remains low but improving.
4. Prevalence of the hepatitis C virus (HCV) is estimated to be between 0.4 to 1% of the United Kingdom (UK) population, equating to be between 250,000 to 600,000 sufferers. Worldwide there are an estimated 170 million people, about 3% of the world’s population, who are chronically infected with HCV.
5. HCV is a blood-borne ribonucleic acid (RNA) virus that exists as a number of different strains (genotypes) and an important cause of liver disease. The effects of the infection vary from one individual to the next. Some people will remain symptom free, some will develop cirrhosis and others will develop liver failure or hepatocellular (primary liver) cancer.


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid
Intervention Type:AOD disorder harm reduction
Source:Royal College of General Practitioners, UK
Date:2007
Pages:52 p.
Publisher:Royal College of General Practioners
Place of Publication:London
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:J Health care, prevention and rehabilitation > Health care administration > Health care quality control
G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
B Substances > Drugs and alcohol in general
J Health care, prevention and rehabilitation > Health care programme or facility > Community-based treatment (primary care)
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control
J Health care, prevention and rehabilitation > Prevention by sponsor or setting > Community-based prevention

Repository Staff Only: item control page